Company insider plans sale of 30,617 shares

A company insider has filed a Form 144 indicating an intent to sell 30,617 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $1,337,035.20.

Rhea-AI Filing Summary

A company insider has filed a Form 144 indicating an intent to sell 30,617 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $1,337,035.20. The shares, classified as performance shares, were acquired from the issuer on 02/15/2026, with the same date listed for payment. The approximate sale date is 02/17/2026 on the NASDAQ market. Over the prior three months, Christopher J. Senner sold 34,278 common shares for $1,473,964.28. By signing the notice, the seller represents that they are not aware of undisclosed material adverse information about the issuer.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for EXEL indicate?

The Form 144 shows an insider’s intent to sell 30,617 common shares with an aggregate market value of $1,337,035.20. It is an advance notice for a potential sale, not confirmation that the transaction has already occurred.

How many EXEL shares are planned to be sold and when?

The filing indicates a planned sale of 30,617 common shares, with an approximate sale date of February 17, 2026. The transaction is to be executed through Morgan Stanley Smith Barney LLC on the NASDAQ market.

What type of EXEL securities are involved in this Form 144?

The securities are common stock acquired as performance shares on February 15, 2026 from the issuer. The same date is listed for payment, and the filing describes the nature of payment as not applicable, implying non-cash performance-based acquisition.

What prior EXEL stock sales are disclosed in the Form 144?

The notice reports that Christopher J. Senner sold 34,278 common shares in a prior transaction on February 13, 2026. Those shares generated gross proceeds of $1,473,964.28, covering all relevant sales in the past three months.

Which broker will handle the planned EXEL stock sale?

The planned sale is to be handled by Morgan Stanley Smith Barney LLC, Executive Financial Services, at its New York Plaza office. The shares are intended to be sold on the NASDAQ exchange, according to the details provided in the notice.

What representation does the EXEL insider make by signing Form 144?

By signing, the insider represents they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed. This representation also applies as of any Rule 10b5-1 plan adoption date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/17/2026 - 06:45 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001648367
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	EXELIXIS, INC.
SEC File Number	000-30235
Address of Issuer	1851 Harbor Bay Parkway Alameda CALIFORNIA 94502
Phone	(650) 837-7000
Name of Person for Whose Account the Securities are To Be Sold	CHRISTOPHER J SENNER
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	30617	1337035.20	259708689	02/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/15/2026	Performance Shares	Issuer			30617	02/15/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
CHRISTOPHER J SENNER 1851 Harbor Bay Parkway Alameda CA 94502	Common	02/13/2026	34278	1473964.28

144: Remarks and Signature

Remarks
Date of Notice	02/17/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Christopher Senner
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)